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RESUMO 
 
Estudos epidemiológicos evidenciaram um aumento da prevalência de periodontite 
crônica (PC) em pessoas idosas com diabetes mellitus tipo 2 (DM2) e sugeriram que 
a terapia periodontal (TP) pode melhorar o seu controle glicêmico. O presente 
trabalho tem o objetivo de relatar os resultados de uma revisão sistemática com 
metanálise e responder a seguinte pergunta: o tratamento periodontal é efetivo para 
diminuir os índices glicêmicos de idosos portadores de diabetes tipo 2 e peridontite? 
Para a obtenção dos dados, foi realizada uma revisão sistemática da literatura, com 
metodologia baseada nos critérios da Cochrane. Todos os estudos clínicos 
randomizados, envolvendo a população de idosos com 60 anos ou mais os quais 
relatassem o efeito da doença periodontal sobre o diabetes mellitus tipo 2 foram 
considerados elegíveis para a presente revisão. Após o processo de seleção dos 
5.856 artigos, 22 estudos foram incluídos na revisão sistemática e 13 na 
metaanálise. Os resultados mostraram um efeito favorável para o tratamento 
periodontal em comparação com não-tratamento. A metaanálise indicou redução 
média de -0,21% HbA1c (IC -0.35, -0.07) após a terapia periodontal em comparação 
com nenhum tratamento (p = 0,003). O teste do qui-quadrado de heterogeneidade 
entre os estudos foi 19,20 e o teste para o efeito global (Z) foi de 3,01. Não foi 
possível determinar implicações clínicas apenas para idosos, uma vez que os 
estudos não mostraram resultados separados por faixa etária. Os resultados da 
metanálise apoiam a eficácia da TP na melhoria do controle glicêmico em pacientes 
com DM2 e PC; no entanto, estudos futuros são necessários para confirmar estes 
resultados em amostras específicas de idosos. 
 
Palavras-chave: Diabetes mellitus tipo 2. Periodontite. Revisão Sistemática. 
Matanálise. 
 
 
ABSTRACT 
 
Epidemiologic studies have reported increased prevalence of chronic periodontitis 
(CP) in older people with type 2 diabetes mellitus (T2DM) and some have suggested 
that periodontal therapy (PT) may improve their glycemic control. The aim of this 
study was to answer to the following question: ‘‘Does PT improve glycemic control in 
older people with both T2DM and CP?’’. This meta-analysis was conducted 
according to the Cochrane Collaboration. A search of electronic databases was 
performed for randomized controlled trials involving older people samples and 
reporting the effects of PT on T2DM. Weighted mean differences (MD) and 95% 
confidence intervals (CI) were calculated for HbA1c. All outcomes were evaluated as 
changes from baseline to the end of follow-up. Heterogeneity was assessed with the 
x2-based Cochran Q and Z tests, and I2 statistic (α=0.05). After the selection process 
of the 5,856 papers, 22 studies were included in the systematic review and 13 in the 
meta-analysis. The results showed a favorable effect for the periodontal treatment 
compared to non-treatment. A meta-analysis indicated a mean treatment effect of -
0.21% HbA1c (CI -0.35, -0.07) compared to no treatment after periodontal therapy (p 
= 0.003). The Chi-square test of heterogeneity among studies was 19.20 and the test 
for the overall effect (Z) was 3.01. The clinical implications only for older people were 
not possible to determine, since the trials not showed results separated by age 
group. The meta-analysis results seem to support the effectiveness of PT in the 
improvement of glycemic control in patients with both T2DM and CP; however, future 
studies are needed to confirm these results in specific older people samples. 
 
Keywords: Type 2 diabetes mellitus. Periodontitis. Systematic review. Meta-
analysis. 
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INTRODUÇÃO 
O aumento da expectativa de vida em todo o mundo é atribuído, 
principalmente, à diminuição das taxas de mortalidade entre os idosos e ao declínio geral 
nas taxas de natalidade. A proporção crescente de idosos faz com que estudos 
envolvendo esses pacientes tenham grande importância para os serviços de saúde. 
Primeiro porque a demanda por atendimento odontológico vai aumentar tanto os para 
idosos ativos, como para os fragilizados; segundo, porque as autoridades de saúde 
pública terão de enfrentar a crescente carga de doenças bucais associadas com o novo 
perfil de doenças crônicas do envelhecimento da população. A incapacidade de lidar com 
as rápidas mudanças nos padrões das doenças, bem como com suas interrelações terá 
consequências socioeconômicas e políticas importantes para os países (Kandelman et al., 
2008).  
Muitas funções essenciais para os seres humanos são executadas pelo 
sistema estomatognático: fala, mastigação, deglutição e socialização. O envelhecimento 
afeta os tecidos orais, como qualquer outra parte do corpo humano, pois ocorrem muitas 
alterações no sistema estomatognático com a idade que podem afetar a qualidade de vida 
(Kossioni e Dontas, 2007). A presença de doenças sistêmicas e o uso de medicamentos, 
comuns entre idosos, também podem prejudicar a saúde bucal. Portanto, a troca de 
informações entre médico e dentista é muito importante no cuidado à saúde desses 
pacientes (Kossioni e Dontas, 2007). 
A importância da manutenção dos dentes em idade mais avançada faz com 
que as doenças periodontias tornem-se preocupações ao longo da vida. A doença 
periodontal é mais grave e menos prontamente controlada em pacientes com diabetes e o 
controle glicêmico pode prejudicar ou exacerbar a resposta do hospedeiro (Shay, 2002). 
Em outro sentido, quando realizado o tratamento periodontal, parece haver melhora do 
controle glicêmico nos pacientes diabéticos (Preshaw e Bissett, 2013). 
O diabetes mellitus é uma doença crônica considerada uma condição de saúde 
importante para o envelhecimento da população, pois indivíduos diabéticos mais velhos 
têm maiores taxas de morte prematura, incapacidade funcional e doenças coexistentes. 
Idosos com diabetes também estão em maior risco do que outros adultos mais velhos 
para várias síndromes geriátricas comuns, como o uso de polifármacos, 
comprometimento cognitivo, incontinência urinária, quedas e dores persistentes (Kirkman 
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et al, 2012; American Diabetes Association, 2015). Dessa forma, a manutenção do 
controle glicêmico adequado é um importante meio de reduzir os custos de morbidade, 
mortalidade e de cuidados médicos associados à enfermidade (Engebretson et al., 
2013a), principalmente quando lidamos com pacientes idosos.  
A partir do exposto, este estudo foi desenhado em um artigo de revisão 
sistemática com metanálise no qual se buscou evidências da relação entre o efeito do 
tratamento periodontal para o controle glicêmico de pacientes idosos portadores de 
diabetes tipo 2. 
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ABSTRACT 
Background: Epidemiologic studies have reported increased prevalence of chronic 
periodontitis (CP) in older people with type 2 diabetes mellitus (T2DM) and some 
have suggested that periodontal therapy (PT) may improve their glycemic control. 
The aim of this study was to answer to the following question: ‘‘Does PT improve 
glycemic control in older people with both T2DM and CP?’’ Methods: This meta-
analysis was conducted according to the Cochrane Collaboration. A search of 
electronic databases was performed for randomized controlled trials involving older 
people samples and reporting the effects of PT on T2DM. Weighted mean 
differences (MD) and 95% confidence intervals (CI) were calculated for HbA1c. All 
outcomes were evaluated as changes from baseline to the end of follow-up. 
Heterogeneity was assessed with the x2-based Cochran Q and Z tests, and I2 
statistic (α=0.05). Results: After the selection process of the 5,856 papers, 22 
studies were included in the systematic review and 13 in the meta-analysis. The 
results showed a favorable effect for the periodontal treatment compared to non-
treatment. A meta-analysis indicated a mean treatment effect of -0.21% HbA1c (CI -
0.35, -0.07) compared to no treatment after periodontal therapy (p = 0.03). The Chi-
square test of heterogeneity among studies was 19.20 and the test for the overall 
effect (Z) was 3.01. The clinical implications only for older people were not possible 
to determine, since the trials not showed results separated by age group. 
Conclusion: The meta-analysis results seem to support the effectiveness of PT in 
the improvement of glycemic control in patients with both T2DM and CP; however, 
future studies are needed to confirm these results in specific older people samples. 
 
Keywords: Type 2 diabetes mellitus, Periodontitis, Systematic review, Meta-analysis 
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INTRODUCTION 
The increase in life expectancy is, without a doubt, one of the greatest 
achievements of humanity1, 2.However, older people have greater health needs and 
long-term care than younger ones2, since a considerable portion of the older people 
population develops important systemic conditions becoming more dependent on 
medical care and generating greater spending for health systems3. This shows that 
aging and age-related diseases are a growing challenge for individuals, their families 
and social, economic and health systems1, 2.  
Currently, one of the most prevalent diseases that affect a large part of the 
older people population is diabetes mellitus4. Diabetes mellitus is a complex chronic 
disease resulting from the imbalance of blood glucose levels and is associated with 
long-term damage, such as dysfunction and failure of various organs, especially the 
eyes, kidneys, nerves, heart and blood vessels, requiring ongoing medical care with 
multifactorial risk reduction strategies in addition to glycemic control5. It is an 
important health condition for the aging of the population, because at least 20% of 
patients aged over 65 years have diabetes, and this number should grow rapidly in 
the coming decades. Older diabetics have higher rates of premature death, functional 
incapacity and coexisting diseases. Older people with diabetes are also at greater 
risk than other older adults in relation to many common geriatric syndromes, such as 
polypharmacy, cognitive impairment, urinary incontinence, falls and persistent pain6. 
Thus, the establishment and maintenance of an adequate glucose control is an 
important means of reducing the costs of morbidity, mortality and medical care 
associated with the disease8, especially when addressing older people patients. In 
this way, the complications of the diseases, which are many, can be avoided. 
The most prevalent category of the disease is type 2 diabetes mellitus 
(T2DM), which affects approximately 90-95% of individuals with this condition. This 
type of diabetes presents age, obesity and lack of physical activity as established risk 
factors5.  
Current research suggests that there is a strong association between type 
2 diabetes and periodontitis9, 10, 11, 12, 13, 14, 15. The relationship of influence between 
these two diseases appears to be bidirectional, with a disease interfering with the 
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prognosis of the other4. Because of the proposed bidirectional relationship between 
T2DM and periodontitis, researchers have studied whether periodontal therapy 
improves the metabolic control in patients with T2DM 8 and periodontal treatment has 
been associated with a clinically significant glycemic control in diabetic patients16. 
However, the effects of periodontal therapy on diabetes control in older people 
patients and their long-term benefits are not yet known17. 
Considering the growing population of older people, the global epidemic of 
diabetes among the elderly, with its complications that contributes to significant 
morbidity and premature mortality, and the possibility of synergisms between 
periodontitis and diabetes, it is appropriate to review the role of periodontitis in 
diabetes, seeking answers that lead to an improvement in the context of the health of 
patients. It is also important to provide guidelines on the periodontal treatment in 
patients with diabetes for the professionals responsible for them, as well as dental 
and medical recommendations addressed toward patients interested, based on solid 
scientific evidence on the relationship between the two diseases4. 
The aim of this study was to answer to the following question: ‘‘Does 
periodontal treatment improve glycemic control in older people with both T2DM and 
Chronic Periodontitis?’’ 
 
MATERIAL AND METHODS 
Types of studies and participants 
This systematic review was registered at Prospective Register of 
Systematic Reviews (PROSPERO) under number of CRD42015025569. This study 
used the five components known by the acronym “PICOS”18: patient population (P); 
the intervention group (I); comparison group (C); outcome of interest (O); and the 
study design (S). 
The study population was composed by a sample that included older 
people (aged 60 years or over) with type 2 diabetes mellitus and periodontitis. The 
intervention chosen was periodontal therapy, surgical or non-surgical, with or without 
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the use of antibiotics, antiseptics, adjuvants or oral hygiene instruction. The chosen 
of control group was the group without subgingival periodontal treatment or the group 
with reduced periodontal care in relation to the intervention group. Both the Control 
group (CG) without periodontal treatment and the Interventional Group (IG) with 
treatment were considered for inclusion. The outcome of interest was the change in 
the glycated hemoglobin indexes (HbA1c) and the study design of interest was 
randomized clinical trials with at least 3 months of follow-up. 
Research Strategy 
To obtain the data, a systematic review of the literature was performed 
with methodology based on both the Cochrane criteria19 and Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA)20. All randomized 
clinical trials that involved the older people population in their sample and that tested 
the effect of periodontal disease therapy on type 2 diabetes mellitus were considered 
eligible for this review. The study selection was conducted in two phases: (1) 
abstracts and titles were selected and (2) the full texts of selected titles were 
obtained and read to determine the final sample.  
The databases used for the survey of articles were the Web of Knowledge, 
the Latin-American and Caribbean Center on Health Sciences Information (LILACS), 
the Cochrane Library and the US National Library of Medicine, National Institute of 
Health (PubMed).  
The inclusion criteria for the selection of articles were: a) studies with 
human subjects; b) which included the older people population (60 years or over); c) 
published in English language; d) published until July 31, 2014; e) periodontal 
disease associated with type 2 Diabetes mellitus; and, f) randomized clinical trials. 
To identify studies included or considered for this review, a research 
strategy was developed for the electronic databases, using keywords from the list of 
Health Sciences Descriptors (DeCS) and Medical Subject Headings (MeSH) and 
their combinations. The following keywords were used: Diabetes Mellitus; Diabetes 
Mellitus, Type 2; Chronic Periodontitis; Aggressive Periodontitis; Periodontitis; 
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Periodontal disease. The terms were used for search by combining two words for 
research. 
Selection of Studies and data extraction 
Initial surveys were carried out by two independent researchers (LFP and 
FRS), who located and selected the articles. The selection of articles based on title 
and abstract was performed independently.  
The researchers read the title of the article, and if it provided sufficient 
data for the exclusion of the text, it would be excluded. If the title met the inclusion 
criteria, the article was included for review. If the title of the article did not provide 
sufficient information for inclusion or exclusion, the researchers would read the 
abstract and chosen between including or excluding it. If there was a repetition of the 
same paper, the copy was excluded and classified as repeated. This procedure was 
performed in all databases. 
After a systematic search and inclusion of articles, a first meeting of 
consensus was performed to address questions and differences between the data 
collected. The next step was the search and reading of the full articles selected by 
titles and subsequent assessment to be included in the sample. Each researcher 
filed a standardized form in Microsoft Excel (2008) with the following data: authors, 
year of publication, country, type of study, sample, age, criteria used to assess 
diabetes, criteria used to assess periodontal disease, drug used, treatments, 
description of the treatment, outcome (whether or not there was association between 
diseases) and statistical analysis. A second meeting of consensus happened among 
researchers to address questions and differences between the articles read and the 
filling out of the form. The studies that met all the criteria established were 
considered in the final analysis. Possible disagreements throughout the process 
were resolved through consensus or by a third party researcher (VSCB). 
Assessment of the Quality and Risk of Bias  
The assessment of the quality of the articles was conducted using the 
JADAD scale21 by two independent assessors (LFP and VSCB), and the 
disagreements were resolved by consensus, as demonstrated in the Figure 1. This 
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scale was suggested by COCHRANE for the assessment of systematic reviews of 
randomized clinical trials. It assess the articles in five different parameters: a) Was 
the study described as randomized?; b) Was the method appropriate?; c) Was the 
study described as double blind?; d) Was the method appropriate?; e) Was there a 
description of withdrawals and dropouts? The score were as follows: each item 
receives one point for each “yes” or zero point for each “no”; an additional point is 
awarded if, in item 1, the random sequence generation method was described and 
appropriate; in item 2, if the double-blind masking method was described and 
appropriate. One point is deducted if, in item 1, the random sequence generation 
method was described, but was inappropriate; in item 2, if it was described as 
double-blind, but was inappropriate. The risk of bias is assessed according to the 
result of the assessment of quality; the final score ranges from 0 to 5 points and the 
stronger the work, the lower the risk of bias. Therefore, the study will be considered 
strong and of low risk of bias when it receives a score greater/equal to 3. 
Summary of the results 
The data were submitted to meta-analysis that was performed in studies 
whose results were similar through RevMan software (Review Manager, Version 5.3. 
Copenhaga: O Nordic Cochrane Centre, The Cochrane Collaboration, 2011). The 
heterogeneity among the studies was calculated using the Chi-Square test of 
homogeneity and the overall effect of the Z-score with p-value by means of the 
RevMan, and the forest plot was generated for this comparison.  
Risk of publication bias among studies 
A funnel plot was built to assess the effect of publication bias according to 
the method described by Sutton et al.22 and was represented in Figure 2. 
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RESULTS 
Search Results 
The search in electronic bases resulted in 5,856 articles. After removing 
duplicates, a total of 4,834 articles were excluded based on the assessment of the 
title or abstract. 499 articles were identified for complete reading. After this process, 
22 studies were included for review, being 6 articles included in the Web of 
Knowledge and 16 articles included in Pubmed. This process, including the reasons 
for exclusion by title, abstract and full article, was described in Figure 3.  
Description of studies included 
22 studies were included in the final sample. The details about the 
methodology, intervention groups and control group, protocols and results were 
summarized in Table 1. Among the articles included, there was diversity of countries 
that have already worked with the subject proposed in this review: Turkey23, 
Thailand24, United States25, 26, 27, 28, China29, 30, 31, 32, Japan33, Jordan34, Greece35, 
Iran36, Malaysia37, Brazil38, 39, 40, 41, 42, Saudi Arabia43 and Poland44. The duration of 
the follow-up period of the selected studies was at least three months, and the study 
of Miranda et al.42 was the one that monitored the patients for the longest period of 
time (12 months). The largest study in terms of sample size was by Engebretson et 
al.28 (514 patients in total).  
Thirteen interventions included non-surgical periodontal treatment, with or 
without adjuvant systemic or topical antibiotics and/or topical antiseptics in the 
Intervention Group23, 24, 26, 27, 28, 29, 30, 31, 32, 33, 35, 36, 37, two of which also included tooth 
extraction of irrecoverable elements30, 36. In these thirteen studies, the control group 
did not receive treatment with scaling and root planning, receiving only oral hygiene 
instruction, mechanical removal of supragingival bacterial plaque/prophylaxis, usual 
care or even no care. 
Among those thirteen studies, five followed patients for up to three 
months23, 24, 30, 36, 37. Three studies followed patients for four months26, 27, 29 and five 
studies followed patients for up to six months28, 31, 32, 33, 34. Six studies showed 
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significant improvement in HbA1c levels in the intervention group compared to control 
group23, 30, 31, 32, 35, 36.  
The study of Promsudthi et al.24 was the only selected study that included 
only older patients (between 55 and 80 years) and included 52 patients in total (27 in 
the Intervention Group and 25 in the Control Group). The treatment established for 
the Intervention Group was oral hygiene instruction, associated with scaling and root 
planning using 100 mg of Doxycycline daily for two weeks, while the Control Group 
remained without treatment until the end of the studies. Notwithstanding the 
reduction in the HbA1c levels in the Intervention Group, the statistical analysis 
showed no significant differences in the glycemic control after periodontal therapy. 
The study of Grossi et al.25 included patients with the lowest chronological age (25-65 
years). 
A study established as treatment protocol for the Intervention Group the 
tooth extraction of all elements without the use of antibiotics and no periodontal 
treatment for the control group34, having been the only one with this treatment 
protocol. It should be noted here that the researchers included in this study only 
patients with advanced periodontitis, whose remaining teeth had indication of tooth 
extraction. The follow-up of these patients was six months and there was significant 
improvement in HbA1c levels in the intervention group compared to control group. 
Although other systematic reviews8, 45, 46, 47 have excluded from analysis 
some well conducted clinical trials because of the lack of a non-treatment group for 
comparison, we opted to include them in this review, doing its analysis aside, 
qualitatively. We agree with the idea that until it is established in larger clinical trials 
that the periodontal treatment contributes or not to the glycemic control in persons 
with diabetes, small studies that compare different methods of treatment may not 
help to answer the central question of the review. However, as in the included studies 
the control group received reduced periodontal treatment in relation to the 
intervention group, the goal of our analysis will be to verify that this "plus" in the 
intervention group was able to bring better results for glycemic control.  
The present study founded eight studies that established different 
periodontal treatment protocols for the intervention group and the control group25, 38, 
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39, 40, 41, 42, 43, 44. The protocols of the Intervention Groups consisted of non-surgical 
periodontal treatment with adjuvant systemic or topical antibiotics and/or topical 
antiseptics. Four studies included the use of antibiotics in the intervention group and 
placebo in the control group, maintaining the same clinical protocol between 
groups25, 40, 42, 44.Two studies included more than one intervention group25, 43. Two 
studies included the use of photodynamic therapy in the intervention group41, 43. One 
study included tooth extraction of irrecoverable elements39.  
Among those eight studies that established different treatment protocols 
between the groups, three studies showed significant improvement in HbA1c levels in 
the intervention group compared to the control group25, 41, 43. In the study of 
O´Connell et al.38 the intervention group showed a significant improvement in 
glycemic control; however, in the analysis between groups, there was no difference 
between the control group and the intervention group. In the study of Macedo et al.41, 
which showed improvement in the HbA1c indexes, the only difference in treatment 
between the two groups was the use of photodynamic therapy in the intervention 
group. Photodynamic therapy has been pointed out as a promising adjuvant to basic 
periodontal therapy, as it has been shown to be effective in reducing bacteria, 
including periodontal bacteria48. 
Results of the Meta-analysis 
For the meta-analysis, studies showed similar interventions were 
considered (13 studies in total). Only the outcome of interest, that is, the comparison 
between the effects of the periodontal treatment versus no treatment on the HbA1c 
levels, was submitted to meta-analysis. The results showed a favorable effect for the 
periodontal treatment compared to non-treatment. A meta-analysis indicated a mean 
treatment effect of -0.21% HbA1c (CI -0.35, -0.07) compared to no treatment after 
periodontal therapy (p = 0.003). The Chi-square test of heterogeneity among studies 
was 19.20 and the test for the overall effect (Z) was 3.01 (Table 2). 
Of the 22 studies selected for this review, 9 were excluded from the meta-
analysis for the following reasons: 
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 One study34 established as protocol of the intervention group the 
tooth extraction of all elements, being the only one with this protocol 
and therefore could not be compared to any other study. 
 Eight studies showed heterogeneous and diverse intervention 
protocols for the intervention group and control group, thus we 
could not perform their meta-analysis nor compare what treatment 
was more effective25, 38, 39, 40, 41, 42, 43, 44. 
 
DISCUSSION 
Among the 22 studies selected for this review, the study of Promsudthi et 
al.24 included patients with the highest chronological age (up to 80 years). All other 
studies included elderly patients, without separating the results according to age, 
which prevented us from performing an analysis of the results by age group. Other 
systematic reviews8, 45, 46, 47 were found linking diabetes with periodontal disease. 
However, none of these reviews studied the effect of periodontal treatment in the aid 
of the glycemic control specifically in elderly patients. 
This issue must be considered in the interpretation of the findings of this 
review, since the results presented were not specific for the older people but include 
them. We cannot rule that as a potential source of bias; however, it can also serve as 
implications for future research, considering the complications arising from type 2 
diabetes in older people patients. Sun et al.49 stated that the effect of periodontal 
therapy on the control of diabetes in older people patients and its long-term benefits 
were not yet known. Kirkman et al.6 observed that notwithstanding showing a higher 
prevalence of diabetes, compared to any other age group, older individuals have 
often been excluded from controlled randomized trials for treatments and treatment 
targets for diabetes and its conditions. 
Future research on treatments for the control of diabetes should include an 
account of the complexity and heterogeneity of older adults. Studies should include 
patients with multiple comorbidities, dependent life situations and geriatric syndromes 
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in order to increase the scientific knowledge on these populations so as to determine 
the evidence observed in the study in the real situations of populations6. 
Among the seven clinical trials in which the Control Group did not receive 
periodontal therapy and which showed significant improvement in HbA1c levels in the 
Intervention Group compared to the control group23, 30, 31, 32, 34, 35, 36, only one used 
antibiotics in the Intervention Group30. This makes the finding relevant, because, as 
mentioned in the studies that did not use antibiotics in the Control Group, the use of 
systemic medications could potentially mask the effect of the periodontal treatment 
on the HbA1c levels, because it can also act on non-oral infection sources, and, 
therefore, the reduction observed in the HbA1c levels could not be attributed solely to 
the local reduction of periodontal infection23, 30, 31, 32, 34, 35, 36. 
More specifically in the study of Khader et al. 34 who performed tooth 
extraction of all elements in the intervention group without prescription of antibiotics, 
the significant improvement of the HbA1c levels is an important finding because it 
can be attributed solely to the end of the periodontal infection. It should also be noted 
that these patients were followed for six months and that the reduction was significant 
throughout the follow-up period. 
Among the studies in which the control group received some type of 
periodontal intervention25, 38, 39, 40, 41, 42, 43, 44, the treatment protocol used varied 
greatly, and we cannot to reach more accurate conclusions, although three studies 25, 
41, 43 showed significant improvement in the glycemic control comparing the 
Intervention Group to the Control Group. 
Changes in biochemical and physiological processes occur with aging in 
all body tissues, including the periodontium, that is, the periodontal changes only 
related to age do not seem to have clinical significance. However, associations 
between these changes with systemic diseases, medications and behavioral and 
environmental factors can significantly compromise the welfare of the elderly50. In this 
way, results as those found in the present meta-analysis are of paramount 
importance to those responsible for the care of these patients. We emphasize that 
periodontal care can go beyond a direct effect on glycemic control, since the lack of 
such care can lead to gradual loss of teeth fixation in the alveolar bone leading to 
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periodontal pockets, gingival recession, teeth with mobility and, eventually, the loss of 
these elements, which can result in changes in the diversity of food absorption, in this 
way affecting the overall health of the individual51. 
Type 2 diabetes mellitus is a health condition that is highly dependent on 
the conduction of regular and healthy eating habits, that is, the health and education 
support for self-management of the diabetes in course are vital components for the 
diabetes care of seniors and their caregivers6 and all healthcare professionals should 
aim to promote oral health in patients with diabetes not only to reduce the burden of 
oral diseases and prevent tooth loss, but to contribute to a better glycemic control49. 
A fact that can be pointed out as important in this review was that, of the 
22 studies included at the end, only six24, 25, 29, 30, 31, 33 presented a final value below 
3 for the JADAD assessment, showing the high level of quality of the selected 
studies. Another point that can be highlighted as enriching in this review is the 
diversity of countries found that did studies with the proposed subject, thus showing 
an important population variety and adding a large number of patients to this review, 
amounting to 1,711 patients in total from different countries23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 
33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44. 
Despite the population diversity founded and the high number of patients 
allocated in the final sample set, it is important to highlight that a limitation of the 
present study was not find articles that analyzed the subject proposed in this review 
exclusively in older people samples (60 years or over). 
 
CONCLUSION 
The meta-analysis results seem to support the effectiveness of PT in the 
improvement of glycemic control in patients with both T2DM and CP; however, future 
studies are needed to confirm these results in specific older people samples. 
The findings of this review also bring important implications for future 
research: 
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 The sample size should be large enough to present the results by age group 
separately. 
 The sample should include only patients over 60 years of age. 
 The sample must include elderly diabetics considering other comorbidities 
associated together in order to be more representative of the reality of these 
patients. 
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Figure 1: Assessment of articles by Jadad Scale20.  
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Figure 2: Funnel plot of comparison of periodontal therapy outcomes (mm) and changes in HbA1c (%). 
SE=Standard error; MD=Mean Difference 
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Figure 3: Flowchart of the study selection 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(2767) Pubmed 
(3034) 
Web of Knowledge 
(30) LILACS 
(5333) titles and/or 
abstracts read 
 4834 articles excluded by title and abstract 
 1860 excluded from the Pubmed database 
 2927 excluded from the ISI Web of Knowledge 
 22 excluded from the LILACS database and 
 25 excluded from Cochrane Library 
 
 Reasons for exclusion: 
 It does not assess per. dis. with diabetes (1806) 
 Review study (1720) 
 Another type of diabetes (550) 
 Incompatible age (481) 
 Case report (137) 
 Other reasons (140) 
(499) complete articles 
selected to be read 
(22) articles selected for 
Systematic Review:  
 6 articles included from the Web of Knowledge 
database 
 16 articles included from the Pubmed database 
477 complete articles excluded 
 Reasons for exclusion: 
 It is not a randomized clinical trial: observational studies, 
review or non-randomized clinical trials (467)  
 It does not include elderly individuals (04) 
 Another type of diabetes (02) 
 Methodology was not clear on the inclusion of elderly 
patients, did not mention age (02) 
 Assess other hematological changes other than glucose 
control (01) 
 Presents a protocol for randomized clinical study, no 
presentation of results (01) 
(25)  
Cochrane Library 
(13) articles selected for 
Meta-analysis 
 2 articles included from the Web of Knowledge 
database 
 11 articles included from the Pubmed database 
523 articles excluded for duplicity 
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Table 1: Summary of the methodology and results of the 22 studies selected for review. 
 
Author, year 
(country) 
type of study 
Number 
of 
patients 
(IG/CG) 
Age 
(years) 
Inclusion criteria 
(periodontal 
disease) 
Inclusion 
criteria 
(diabetes) 
IG Treatment CG Treatment 
Mean of HbA1C (%) 
Baseline/follow-up 
(period) 
Comments on the 
results found in 
glycemic control 
Kiran et al., 2005
22
 
(Turkey) 
Randomized, open-label 
22 / 22 31-79 
Moderate 
periodontitis no 
specificated 
HbA1C Levels: 
6% ≥ 8 % 
OHI + SRP No treatment 
IG: 7.31/6.51 
CG: 7.00/7.31 
(3rd month) 
IG showed a significant 
reduction in HbA1c. 
Promsudthi et al., 2005
23
 
(Thailand) Randomized, 
open-label 
30 / 30 55-80 
≥ 14 teeth with ≥ 8 
sites with CAL ≥ 5 
mm and PD ≥ 5 
mm 
HbA1C levels: 
7.5% ≥ 11 % 
OHI + SRP + 
doxycycline 100 
mg day / 2 weeks 
Received no 
treatment 
IG: 8.98/8.78 
CG: 9.17/9.28 
(3rd month) 
No significant 
differences between 
both groups 
Jones et al., 2007
26 
(EUA) 
Randomized, blind 
(multicenter) 
82 / 83 
 
Mean 
of age 
59.1 
≥ 8 teeth 
CPITN ≥ 3 in at 
least two sextants 
HbA1C Levels: ≥ 
8.5% 
SRP + doxycycline 
100 mg day / 14 
days + 
chlorhexidine 
gluconate 0.12% 
2X day / 4 months 
Regular care of 
the patient, 
without treatment 
IG: 9.9/9.3 
CG: 10.2/9.6 
(4th month) 
No significant 
differences between 
both groups. 
CG had more chances 
to require adjustments 
in insulin doses than IG. 
Yun et al., 2007
28
 
(China) 
Randomized, open-label 
23 / 23 
Mean 
of age  
53.41 
(IG) 
55.10 
(CG) 
≥ 14 teeth 
PD: ≥ 5 mm and < 
8 mm in at least 4 
teeth or two 
quadrants. 
Bleeding and/or 
suppuration on 
probing 
DM2 diagnosis 
done by a 
physician 
SRP + doxycycline 
100 mg day / 14 
days 
Doxycycline 100 
mg day / 14 days, 
with no 
periodontal 
treatment 
IG: 8.26/7.49 
CG: 8.22/7.64 
(4th month) 
There was no significant 
difference between the 
two groups. 
Katagiri et al., 2009
32
 
(Japan) 
Randomized, open-label 
32 / 17 39-75 
≥ 11 teeth 
≥ 2 sites with PD ≥ 
4 mm 
HA1C Levels: 
6.5% ≥ 10 % 
SRP + 10 mg of 
topic minocycline 
ointment 
OHI 
IG: 7.2/7.1 
CG: 6.9/6.9 
(3rd month) 
There was only a 
statistically significant 
change in IG. 
Khader et al., 2010
33
 
(Jordan) 
Randomized, open-label 
29 / 29 
42-73 
(IG) 
37-72 
(CG) 
≥ 8 teeth 
100% of teeth with 
indicated tooth 
extraction 
HA1C Levels: ≥ 
7% 
Tooth extraction of 
all elements, 
without prescribing 
antibiotics 
OHI and no 
treatment 
throughout the 
study 
IG: 8.6/7.4 
CG: 7.7/7.5 
(3rd month) 
There was only a 
statistically significant 
change in IG 
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Table 1: Continuation 
 
Author, year 
(country) 
type of study 
Number 
of 
patients 
(IG/CG) 
Age 
(years) 
Inclusion criteria 
(periodontal 
disease) 
Inclusion 
criteria 
(diabetes) 
IG Treatment CG Treatment 
Mean of HbA1C (%) 
Baseline/follow-up 
(period) 
Comments on the 
results found in 
glycemic control 
Koromantzos et al., 2011
34 
(Greece) 
Randomized, blind 
30 / 30 40-75 
≥ 16 teeth 
PD: 8 sites ≥ 6 
mm 
CAL: 4 sites ≥ 5 
mm 
At least two 
quadrants affected 
A1C Levels: 7% 
≥ 10 % 
OHI +SRP in two 
sessions, a week 
apart 
OHI + Prophylaxis 
and mechanical 
removal of 
supragingival 
bacterial plaque 
IG: 7.87/7.14 
CG: 7.59/7.41 
(3rd month) 
Significant improvement 
in glycemic control after 
six months. 
Sun et al., 2011 
29 
(China) 
Randomized, open-label 
82 / 75 36-70 
> 20 teeth 
PD > 5mm 
> 30% of teeth 
CAL > 4mm OR > 
60% of teeth PD > 
4mm and CAL > 3 
mm 
Diagnosis (by 
the WHO 
criteria) for over 
a year 
A1C Levels: 
7.5% ≥ 9.5% 
SRP + Periodontal 
surgery, when 
indicated + Tooth 
extraction of 
affected teeth + 
Restoration for 
occlusion 
balancing + 
Antibiotics 
(Tinidazole and 
Ampicillin). 
No treatment 
IG: 8.75/8.25 
CG: 8.70/8.56 
(3rd month) 
After 3 months, HbA1c 
serum levels 
significantly decreased 
in IG, compared to 
those for CG. 
Chen et al., 2012
 31
 
(China) 
Randomized, blind 
IGa. 45 
IGb: 45 
CG: 44 
38-81 
≥ 16 teeth 
PD: 4% with sites 
≥ 6 mm 
CAL: (average) ≥ 
1 mm 
Confirmed 
diagnosis of 
DM2 for over a 
year, without a 
change in the 
diabetes 
treatment plan in 
the two months 
prior to the 
beginning of the 
study 
IGa: Initial SRP + 
SRP after 3 
months 
 
IGb: Initial SRP + 
Removal of plaque 
after 3 months. 
Individuals did not 
receive treatment 
or formal oral 
hygiene 
instructions until 
the end of the 
study 
IGa. 7.31/7.30 
IGb: 7.29/7.43 
CG: 7.25/7.59 
(3rd month) 
A significant reduction in 
HbA1c was seen in 6 
months in IGb (p<0.05) 
but not in IGa or CG. 
Comparisons between 
groups showed no 
significant difference in 
HbA1c at any point in 
time. 
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Table 1: Continuation 
 
Author, year 
(country) 
type of study 
Number 
of 
patients 
(IG/CG) 
Age 
(years) 
Inclusion criteria 
(periodontal 
disease) 
Inclusion 
criteria 
(diabetes) 
IG Treatment CG Treatment 
Mean of HbA1C (%) 
Baseline/follow-up 
(period) 
Comments on the 
results found in 
glycemic control 
Moeintaghavi et al., 2012
35 
(Iran) 
Randomized, blind 
22 / 18 
Mean 
of age 
50.29 
Mild to moderate 
periodontitis ( AAP 
criteria) 
HA1C Levels: > 
7% 
OHI + emergency 
restorations, tooth 
extraction of 
irrecoverable 
elements + SRP 
OHI + emergency 
restorations, tooth 
extraction of 
irrecoverable 
elements, without 
realization of 
periodontal 
treatment 
IG: 8.15/7.41 
CG: 8.72/8.97 
(3rd month) 
The HbA1c level 
significantly decreased 
after treatment in IG. 
Engebretson et al., 2013
27 
(United States) 
Randomized, blind 
257 / 
257 
Mean 
of age 
56.7 
(IG) 
57.9 
(CG) 
≥ 16 teeth 
CAL and PD ≥ 5 
mm in ≥ 2 
quadrants 
HA1C Levels: 
7% ≥ 9 % 
SRP + 
Chlorhexidine 
0.12% 
(mouthwash) 
Received no 
treatment 
IG: 7.84/7.98 
CG: 7.78/7.88 
(3rd month) 
 
The HbA1c levels did 
not significantly change 
between the initial 
values and follow-ups of 
3 or 6 months, neither in 
IG nor in CG. 
Zhang et al., 2013
30 
(China) 
Randomized, blind 
50 / 25 35-80 
≥ 16 teeth 
≥ 4 teeth with PD 
≥ 5mm, CAL ≥ 4 
mm and BP 
distributed by ≥ 2 
quadrants 
HA1C Levels: ≥ 
5.5% 
1st stage: OHI + 
SRP 
2nd stage: IGa. 
SRP + manual 
scaling in pockets 
≥ 4 mm 
IGb: Removal of 
plaque and 
prophylaxis 
No treatment 
IG: 7.68/7.54 
CG: 7.38/7.39 
(3rd month) 
 
Compared to CG, the 
change in the HbA1c 
level of the baseline for 
assessment in the 
treatment group showed 
statistical difference. 
Gay et al., 2014 
25 
(United States) 
Randomized, blind 
77 / 77 
Mean 
of age  
51.5 
(IG) 
54.0 
(CG) 
Severe chronic 
generalized or 
localized 
periodontitis (AAP 
criteria) 
A1C Levels: ≥ 
6.5%.  
A1C: 5.7 ≥ 6.5% 
taking 
hypoglycemic 
drugs. 
OHI + SRP OHI IG: 9.0/8.4 
CG: 8.4/8.1 
(4th month) 
The association 
between changes in 
HbA1c levels after 
periodontal treatment 
was not significant. 
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Table 1: Continuation 
 
Author, year 
(country) 
type of study 
Number 
of 
patients 
(IG/CG) 
Age 
(years) 
Inclusion criteria 
(periodontal 
disease) 
Inclusion 
criteria 
(diabetes) 
IG Treatment CG Treatment 
Mean of HbA1C (%) 
Baseline/follow-up 
(period) 
Comments on the 
results found in 
glycemic control 
Raman et al., 201436 
(Malaysia) 
Randomized 
 
20 / 20 30-70 
Moderate to 
advanced 
periodontitis 
≥ 12 teeth 
≥ 5 sites with PD ≥ 
5 mm  
CAL ≥ 4 mm in ≥ 2 
sites in 2 different 
quadrants 
DM2 confirmed 
for over a year 
SRP + 
Chlorhexidine 
0.12% 
(mouthwash) 3X 
day / 14 days 
OHI 
IG: 7.8/7.1 
CG: 7.6/7.1 
(3rd month) 
Although the IG 
demonstrated a 
significant reduction in 
HbA1c levels when 
comparing the baseline 
values with the values 
for three months, the 
comparison between 
the groups showed no 
significant difference. 
Grossi et al., 1997 
24 
(United States) 
Randomized, blind 
113 
patients 
in total 
25-65 
Moderate to 
severe 
periodontitis (does 
not specify criteria) 
Type 2 diabetes 
in accordance 
with the WHO 
criteria 
IGa. SRP + water 
+ doxycycline 
 
IGb: SRP + 
chlorhexidine 
0.12% + 
doxycycline 
 
IGc: SRP + 
povidone-iodine + 
doxycycline  
 
IGd: SRP + 
chlorhexidine 
0.12% + placebo; 
CG: SRP + 
irrigation with 
water + placebo 
IGa. 10.5/9.6 
IGb: 10.4/9.9 
IGc: 10.3/9.8 
IGd: 10.7/10.5 
CG: 9.2/8.9 
(3rd month) 
In the first 3 months 
only the groups that 
used doxycycline 
showed significant 
reduction in HbA1c 
levels, but this reduction 
was not extended 
beyond the period of 3 
months. 
O´Connell et al., 2008 
37
 
(Brazil) 
Randomized, blind 
15 / 15 
Mean 
of age 
53.5 
(IG) 
52.3 
(CG) 
≥ 1 site with PD ≥ 
5 mm; and 
≥ 2 teeth with CAL 
≥ 6mm 
HA1C Levels: > 
8% 
SRP + doxycycline 
100 mg day 
SRP 
IG: 11.8/10.3 
CG: 10.7/9.8 
(3rd month) 
Although the IG 
demonstrated a 
significant reduction in 
HbA1c levels, the 
comparison between 
the groups showed no 
significant difference. 
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Table 1: Continuation 
 
Author, year 
(country) 
type of study 
Number 
of 
patients 
(IG/CG) 
Age 
(years) 
Inclusion criteria 
(periodontal 
disease) 
Inclusion 
criteria 
(diabetes) 
IG Treatment CG Treatment 
Mean of HbA1C (%) 
Baseline/follow-up 
(period) 
Comments on the 
results found in 
glycemic control 
Santos et al., 2009
38 
(Brazil) 
Randomized, blind 
18 / 18 36-75 
≥ 15 teeth 
> 30% sites with 
PD and CAL ≥ 5 
mm 
Diagnosis of 
DM2 in the last 5 
years 
IGa: OHI + SRP 
(entire mouth) in 
two appointments 
with support 
therapy. 
IGb: OHI + SRP in 
four appointments 
with support 
therapy. 
IGa. 9.1/9.8 
IGb: 9.2/9.6 
(3rd month) 
No statistically 
significant differences 
were observed between 
the therapeutic groups 
for any clinical 
parameter at any point 
in time. 
Al-Zahrani et al., 2009
42 
(Saudi Arabia) 
Randomized, blind 
IGa. 15 
IGb: 15 
IGc: 15 
35-77 
≥ 20 teeth 
CAL ≥ 3 mm in ≥ 
30% of sites 
Confirmed 
diagnosis of 
DM2 
IGa - SRP + 
doxycycline 100 
mg  
IGb - SRP + 
photodynamic 
therapy 
IGc – SRP 
IGa. 8.42/7.71 
IGb: 9.25/8.79 
IGc: 8.75/8.22 
(3rd month) 
Mean level of glycated 
hemoglobin decreased 
from the beginning up to 
12 weeks in all groups, 
but was only statistically 
significant in IGa. 
Gilowski et al, 2012
43 
(Poland) 
Randomized, double-blind 
17 / 17 36-68 
≥ 14 teeth 
PD: ≥ 4 mm in at 
least four non-
adjacent sites 
Clinical 
diagnosis of 
DM2 at least six 
months prior to 
the study 
SRP + OHI + 
doxycycline 
hydrochloride 20 
mg 2x/day for 3 
months. 
SRP + OHI + 
placebo 2x/day for 
3 months 
IG: 6.7/6.7 
CG: 6.2/6.3 
(3rd month) 
Mean percentage of 
glycated hemoglobin did 
not change compared to 
the values before 
therapy for both groups. 
Santos et al., 2013
39 
(Brazil) 
Randomized, blind 
19 / 19 35-75 
≥ 15 teeth 
> 30% of 
concomitant sites 
with PD and CAL 
≥ 4 mm PD, 
concomitantly. 
Medical 
diagnosis of 
DM2 in the last 5 
years 
SRP + 
chlorhexidine 
(mouthwash) + 
chlorhexidine 1% 
(irrigation of 
pockets and 
brushing of 
tongue). 
SRP + placebo 
IG: 10.0/9.3 
CG: 10.4/9.7 
(3rd month) 
 
There were no 
significant differences 
between the groups for 
the glycemic parameter 
at any point in time. 
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Table 1: Continuation 
 
Author, year 
(country) 
type of study 
Number 
of 
patients 
(IG/CG) 
Age 
(years) 
Inclusion criteria 
(periodontal 
disease) 
Inclusion 
criteria 
(diabetes) 
IG Treatment CG Treatment 
Mean of HbA1C (%) 
Baseline/follow-up 
(period) 
Comments on the 
results found in 
glycemic control 
Macedo et al., 2014
40 
(Brazil) 
Randomized 
15 / 15 38-61 
≥ 1 site with PD ≥ 
5 mm in each 
quadrant; 
≥ 2 teeth with CAL 
≥ 6mm 
Medical 
diagnosis of 
DM2 for more 
than 5 years 
A1C Levels:>7% 
SRP + doxycycline 
100 mg day + 
photodynamic 
therapy  
SRP + doxycycline 
100 mg day  
IG: 8.6/7.6 
CG: 8.0/7.8 
(3rd month) 
Both groups had a 
reduction in average 
HbA1c levels, but this 
reduction was 
statistically significant 
only in IG. 
Miranda et al., 2014
41 
(Brazil) 
Randomized, double-blind 
29 / 29 
Mean 
of age 
54.0 
(IG) 
53.7 
(CG) 
≥ 15 teeth 
> 30% sites with 
PD and CAL ≥ 4 
mm 
Minimum of six 
sites with PD and 
CAL ≥ 5 mm and 
BP 
Medical 
diagnosis of 
DM2 for more 
than 5 years 
A1C Levels: ≥ 
6.5% ≤ 11 % 
SRP + 
Metronidazole 400 
mg and Amoxicillin 
500 mg 
SRP + placebo. 
IG: 8.53/8.6 
CG: 8.99/8.94 
(3rd month) 
No statistically 
significant differences 
were observed between 
the groups for average 
HbA1c levels at any 
point in time. 
IG: Intervention Group; CG: Control Group; DM2: Type 2 Diabetes Mellitus; PD: Pocket Depth; CAL: Clinical Attachment Loss; SRP: Scaling and Root Planning; CPITN= Community Periodontal 
Index of Treatment Need; AAP = American Academy of Periodontology; HbA1C= Glycated Hemoglobin; Removal of plaque: Mechanical removal of supragingival bacterial biofilm; OHI: Oral Hygiene 
Instruction; BP: Blooding on probing; WHO: World Health Organization. 
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Table 2: Forest plot of comparison: periodontal therapy outcomes and changes in HbA1c (%HbA1c) 
 Treatment Control  Mean Difference Forest plot 
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% CI  
Chen et al., 2012a 
31 
-0.01 1.94 42 0.34 2.14 41 2.3% -0.35 [-1.23, 0.53] 
 
Chen et al., 2012b 
31
 0.14 2.18 41 0.34 2.14 41 2.0% -0.20 [-1.14, 0.74] 
Engebretson et al., 2013 
27 
0.14 0.99 233 0.10 0.96 228 19.1% 0.04 [-0.14, 0.22] 
Gay et al., 2014 
25
 -0.60 2.12 66 -0.30 1.92 60 3.4% -0.30 [-1.01, 0.41] 
Jones et al., 2007 
26 
-0.60 1.21 74 -0.60 0.49 80 12.3% 0.00 [-0.30, 0.30] 
Katagiri et al., 2009 
32
 -0.10 0.85 32 0.00 0.90 17 5.7% -0.10 [-0.62, 0.42] 
Kiran et al., 2005 
22 
-0.80 0.77 22 0.31 1.83 22 2.6% -1.11 [-1.94, -0.28] 
Koromantzos et al., 2011 
34 
-0.73 0.91 30 -0.18 0.82 30 7.4% -0.55 [-0.99, -0.11] 
Moeintaghavi et al., 2012 
35 
-0.74 1.64 22 0.25 2.87 18 0.8% -0.99 [-2.48, 0.50] 
Promsudthi et al., 2005 
23
 -0.20 1.07 27 0.11 1.26 25 4.1% -0.31 [-0.95, 0.33] 
Raman et al., 2014 
36
 -0.70 1.38 15 -0.50 1.37 17 2.0% -0.20 [-1.15, 0.75] 
Sun et al., 2011 
29
 -0.50 0.70 82 -0.14 0.67 75 16.8% -0.36 [-0.57, -0.15] 
Yun et al., 2007 
28
 -0.77 0.30 23 -0.58 0.41 23 17.2% -0.19 [-0.40, 0.02] 
Zhang et al., 2013 
30
 -0.14 1.18 49 0.01 1.23 22 4.4% -0.15 [-0.76, 0.46] 
Total (95%CI)   758   699 100.0% -0.21 [-0.35, -0.07] 
 
Heterogeneity: Tau
2
=0.02; Chi
2
=19.20, df=13(p=0.12); I
2
=32%         -4              -2                0                2               4 
Test for overall effect: Z=3.01 (p=0.003) Favours (Treatment)         Favours (Control) 
HbA1c=Glycosylated Hemoglobin; SD=Standard Deviation; CI=Confidence interval; df=difference 
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CONSIDERAÇÕES 
A presente metanálise representa a melhor e mais robusta evidência 
sobre o efeito do tratamento periodontal no controle glicêmico de iodos diabéticos, 
entretanto, seus resultados devem ser avaliados com cautela, pois representam os 
achados em uma amostra que inclui pacientes idosos e não em uma amostra 
exclusiva de pacientes idosos. 
Foram encontrados nas bases de dados diversos artigos que estudam a 
relação entre a doença periodontal e a diabetes tipo 2. Todavia, ao restringimos a 
pesquisa para uma amostra composta apenas por pacientes idosos, encontramos 
somente um estudo com população entre 55-80 anos de idade. Esse fato pode ser 
apontado como uma limitação deste trabalho. Entretanto, por tratar-se de uma 
revisão sistemática da literatura, que deve contribuir para o desenho de futuras 
investigações, essa situação evidencia a necessidade de que novos estudos sejam 
conduzidos somente com pacientes idosos. 
Ressalta-se como uma consideração do presente estudo que, por tratar-
se de uma revisão sistemática da literatura, a pesquisa foi liberada de aprovação 
pelo Comitê de Ética. No ofício “OF. CEP/FOP N.º 016/2015” apresentado sob a 
forma de anexo 1 consta a referida liberação. 
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DISCUSSÃO 
Durante a busca por artigos que versassem sobre o tema proposto foram 
encontradas nove revisões sistemáticas avaliando o efeito do tratamento periodontal 
no controle glicêmico de pacientes diabéticos. Todavia, nenhuma dela avaliava esse 
efeito em pacientes idosos. 
Dentre as revisões encontradas, quatro avaliaram o efeito da terapia 
periodontal sobre o controle glicêmico tanto em diabéticos do tipo 1 como em 
diabéticos tipo do 2 (Janket et al, 2005; Darré et al., 2008; Simpson et al., 2010; 
Corbella et al., 2013) e cinco avaliaram somente em diabéticos do tipo 2 (Teeuw et 
al, 2010; Sgolastra et al, 2013; Engebretson e Kocher, 2013; Sun et al., 2014; Wang 
et al, 2014). Cinco utilizaram a hemoglobina gicada como medida de análise da 
glicose, tal como no presente estudo (Janket et al, 2005; Darré et al., 2008; Simpson 
et al., 2010; Engebretson e Kocher, 2013; Wang et al, 2014) e quatro utilizaram tanto 
a hemoglobina glicada como a glicose em jejum (Teeuw et al, 2010; Corbella et al., 
2013; Sgolastra et al, 2013; Sun et al., 2014).  
Apenas uma revisão comparou o efeito entre tratamentos periodontais 
distintos (Wang et al, 2014), diferentemente da presente revisão. Wang et al., 2014 
compararam esse efeito a partir da metanálise de quatro ensaios clínicos 
randomizados cujos protocolos estabeleciam para o grupo intervenção o tratamento 
periodontal não-cirúrgico associado à doxiciclina sistêmica e para o grupo controle o 
tratamento periodontal não-cirúrgico e placebo. Não houve melhora significativa a 
favor do uso de doxiciclina no grupo intervenção. Esse achado é interessante, pois 
reforça a ideia de que o tratamento periodontal é efetivo por si só, sem a 
necessidade de adjuvantes antimicrobianos, para auxiliar no controle glicêmico de 
pacientes diabéticos. 
A primeira revisão sistemática com metanálise foi realizada por Janket et 
al., 2005. Os pesquisadores investigaram intervenções periodontais em pacientes 
com diabetes tipo 1 tipo 2 e que tivessem sido acompanhados por pelo menos 2 
meses. A metanálise mostrou uma redução não significativa comparando grupo 
tratado com não tratado. Todavia, os autores observaram que na avaliação visual do 
gráfico da metanálise, houve uma correlação entre o tipo de diabetes e a direção 
45 
 
dos resultados. As pesquisas que investigavam o efeito do tratamento periodontal 
em diabéticos do tipo 2 aparentemente resultavam em efeitos mais fortes na redução 
da HbA1c do que os estudos que investigavam o efeito em diabéticos do tipo1.  
Darré et al., 2008 publicaram uma nova revisão sistemática com 
metanálise e, da mesma forma que Jaket et al., 2005, esses pesquisadores também 
não restringiram o tipo de diabetes para análise. Apesar de terem encontrado um 
resultado significativo a favor do tratamento, os autores ressaltaram que os estudos 
agrupados possuíam amostras individuais pequenas e que o tipo de doença 
periodontal analisado não estava estabelecido de forma clara nos textos dos artigos. 
Em 2010, Teeuw et al. publicaram a primeira revisão sistemática que 
selecionou somente pacientes com diabetes tipo 2 e cujas intervenções tivessem 
sido acompanhadas por no mínimo 3 meses, como no presente estudo. Cinco 
estudos foram submetidos à metanálise e, apesar de terem encontrado um resultado 
significativo a favor do tratamento para HbA1c, os autores relataram as mesmas 
limitações encontradas por Darré et al., 2008. Também foi publicada a revisão 
sistemática realizada por Simpson et al., 2010 que testou a hipótese nula de que o 
tratamento da doença periodontal não melhora o controle da glicemia em pacientes 
diabéticos. Baseados nos resultados da metanálise, os autores foram capazes de 
rejeitar esta hipótese e estimar uma redução percentual média de 0,4% em HbA1c 
associada com o tratamento da doença periodontal, mostrando que há evidência de 
que o tratamento da doença periodontal pode ter um efeito modesto, mas favorável 
no controle metabólico em pessoas com diabetes. Os autores não selecionaram o 
tipo de diabetes na metodologia, todavia os três estudos submetidos à metanálise 
avaliaram o efeito somente em pacientes com diabetes tipo 2. Os autores 
assinalaram ainda que a necessidade de mais estudos para confirmar ou refutar os 
achados deveria ser vista como uma prioridade de saúde pública, tendo em vista a 
prevalência tanto da doença periodontal como do diabetes.  
Em sequência às revisões realizadas anteriormente, Corbella et al. (2013) 
fez a metanálise de 15 estudos e concluíram que o tratamento periodontal pode ser 
eficaz para melhorar o controle metabólico em termos de redução das 
concentrações de HbA1c e glicose em jejum de pacientes com diabetes. Sgolastra et 
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al., 2013 incluíram em uma metanálise 5 estudos para avaliar as variações em 
HbA1c e 4 estudos na glicose em jejum e encontraram uma redução significativa 
tanto para HbA1c como para glicose em jejum. Engebretson e Kocher, 2013 fizeram 
a metanálise de 9 estudos e acharam uma redução significativa para HbA1c e por 
fim, Sun et al., 2014 fizeram a metanálise de 8 estudos e encontraram redução 
significativa para HbA1c e não significativa para glicose em jejum.  
No entanto, todos os pesquisadores consideraram seus resultados 
questionáveis, pois depararam-se com basicamente as mesmas limitações que o 
presente estudo (Janket et al, 2005; Darré et al., 2008; Simpson et al., 2010; Teeuw 
et al, 2010; Corbella et al., 2013; Sgolastra et al, 2013; Engebretson e Kocher, 2013; 
Sun et al., 2014; Wang et al, 2014). As limitações encontradas incluem: amostras 
pequenas; estudos cujos resultados não foram separados por faixas etárias, 
impossibilitando análise desse efeito por idade e; critérios diferentes para definição 
de doença periodontal e diabetes. Esses achados apontam para uma limitação 
importante de toda revisão sistemática: a dependência de estudos primários 
robustos e bem conduzidos para que o resultado da metanálise possa de fato 
responder à pergunta elaborada. 
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CONCLUSÃO 
A Metanálise foi conclusiva apontando que o tratamento periodontal é 
efetivo para auxiliar no controle glicêmico de pacientes diabéticos, quando avaliados 
os resultados de estudos clínicos randomizados que incluíram pacientes idosos. 
Em que pese o fato de não terem sido encontrados artigos que 
analisassem o efeito do tratamento periodontal sobre o controle glicêmico somente 
em pacientes idosos, o que faz com que não se possa chegar a conclusões quanto 
as implicações clínicas específicas para esse grupo populacional, os achados são 
constituem um importante referencial para futuras investigações: 
 Novos estudos deverão avaliar a relação entre as doenças em pacientes 
idosos; 
 No caso de estudos com populações com idades variadas, o tamanho da 
amostra deverá ser suficientemente grande para apresentar os resultados por 
faixa etária separadamente. 
 A amostra deverá incluir idosos diabéticos considerando as demais 
comorbidades associadas presentes, de forma a ser mais representativa da 
realidade desses pacientes. 
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